Difference between revisions of "Filanesib (ARRY-520)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Chemotherapeutic" to "") Tags: mobile edit mobile web edit |
m |
||
| Line 1: | Line 1: | ||
| − | =Mechanism of action= | + | ==Mechanism of action== |
From the [http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=546990 NCI Drug Dictionary]: A synthetic, small molecule targeting the kinesin spindle protein (KSP) with potential antineoplastic activity. KSP inhibitor ARRY-520 specifically inhibits KSP (kinesin-5 or Eg5), resulting in activation of the spindle assembly checkpoint, induction of cell cycle arrest during the mitotic phase, and consequently cell death in tumor cells that are actively dividing. | From the [http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=546990 NCI Drug Dictionary]: A synthetic, small molecule targeting the kinesin spindle protein (KSP) with potential antineoplastic activity. KSP inhibitor ARRY-520 specifically inhibits KSP (kinesin-5 or Eg5), resulting in activation of the spindle assembly checkpoint, induction of cell cycle arrest during the mitotic phase, and consequently cell death in tumor cells that are actively dividing. | ||
| + | |||
| + | ==Also known as== | ||
| + | *'''Code name:''' ARRY-520 | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Revision as of 02:08, 14 December 2020
Mechanism of action
From the NCI Drug Dictionary: A synthetic, small molecule targeting the kinesin spindle protein (KSP) with potential antineoplastic activity. KSP inhibitor ARRY-520 specifically inhibits KSP (kinesin-5 or Eg5), resulting in activation of the spindle assembly checkpoint, induction of cell cycle arrest during the mitotic phase, and consequently cell death in tumor cells that are actively dividing.
Also known as
- Code name: ARRY-520